1CMFRA:IQ70 +188.64%50 Gross Margin % is 19.65% as of Feb. 2026, which is 1% above its 10-year median of 19.54. GuruFocus rates FRA:IQ70 with a GF Score™ of 50/100 and a GF Value™ of €0.25. The stock has 3 warning signs investors should review. Among 937 Drug Manufacturers companies, 1CM ranks worse than 90.39% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. 1CM's Gross Profit for the
three
months ended in Feb. 2026 was €2.17 Mil. 1CM's Revenue for the
three
months ended in Feb. 2026 was €11.06 Mil. Therefore, 1CM's Gross Margin % for the quarter that ended in Feb. 2026 was 19.65%.
The historical rank and industry rank for 1CM's Gross Margin % or its related term are showing as below:
FRA:IQ70'
s Gross Margin % Range Over the Past 10 Years
Min: -50.83 Med: 19.54 Max: 21.53
Current: 21.03
During the past 13 years, the highestGross Margin % of 1CM was 21.53%. The lowest was -50.83%. And the median was 19.54%.
FRA:IQ70's Gross Margin % is ranked worse than 90.39% of 937
companies
in the Drug Manufacturers industry
Industry Median: 48.46
vs FRA:IQ70: 21.03
1CM had a gross margin of 19.65% for the quarter that ended in Feb. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for 1CM was 0.00% per year.
1CM (FRA:IQ70) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
1CM had a gross margin of 19.65% for the quarter that ended in Feb. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
1CM Gross Margin % Related Terms
1CM Gross Margin % Historical Data
* Premium members only.
The historical data trend for 1CM's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1CM Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1CM's Gross Margin % distribution charts can be found below:
* The bar in red indicates where 1CM's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
1CM (FRA:IQ70) has a Gross Margin % of 19.65% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on 1CM and its competitors. This is near median its historical median of 19.54. According to the industry distribution chart, 1CM ranks #847 out of 937 companies in the Drug Manufacturers industry, placing it in the top 90.4%.
Is 1CM's Gross Margin % too high?
1CM's current Gross Margin % of 19.65% is near median its 10-year median of 19.54. The Drug Manufacturers industry median Gross Margin % is 48.46. 1CM's value of 19.65% is 59.5% below this industry median. Based on the distribution chart, 1CM ranks #847 out of 937 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, 1CM has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does 1CM's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, 1CM ranks #847 out of 937 companies for Gross Margin %. This places 1CM in the lower half of its industry. The industry median Gross Margin % is 48.46. 1CM's value of 19.65% is 59.5% below this benchmark. While the company's 10-year median is 19.54 vs. the industry median of 48.46, 1CM has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1CM's current Gross Margin % of 19.65% is 59.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on 1CM and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1CM's current Gross Margin % is 19.65%, which is near median its own 10-year median of 19.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
1CM (FRA:IQ70) has a current Gross Margin % of 19.65%. The stock's GF Value™ is €0.25, compared to a current price of €0.06 — trading 74.6% below its estimated fair value. The current Gross Margin % is 19.65%, which is near median its 10-year median of 19.54 and 59.5% below the Drug Manufacturers industry median of 48.46. 1CM's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For 1CM (FRA:IQ70), the current Gross Margin % is 19.65% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 1CM (FRA:IQ70) Overvalued in 2026?
Based on GuruFocus' analysis, 1CM stock appears to be undervalued.
The current stock price of €0.06 is trading 74.6% below its estimated GF Value™ of €0.25.
Key valuation signals for FRA:IQ70:
Gross Margin %: 19.65% (near median its 10-year median of 19.54)
GF Value™: €0.25 vs. price of €0.06 (74.6% below fair value)
Industry Position: 59.5% below the Drug Manufacturers median (#847 of 937)
No single metric tells the full story. See the FRA:IQ70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.
50GF Score
Get the complete analysis for FRA:IQ70
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IQ70 has been successfully added to your 
